Powder dispersion devices and methods

• US 10,441,733 B2
• Filed: 02/25/2013
• Issued: 10/15/2019
• Est. Priority Date: 06/25/2012
• Status: Active Grant

• Current Assignee: Respira Therapeutics, Inc.
• Original Assignee: Respira Therapeutics, Inc.
• Inventors: Donovan, Martin J.
• Primary Examiner(s): Vasat, Peter S
• Assistant Examiner(s): Heffner, Ned T
• Application Number:
  US13/776,546
• Publication Number:
  US 20130340747A1
• Time in Patent Office: 2,423 Days
• CPC Class Codes: A61M 15/0028 using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
• CPC Class Codes: A61M 15/0033 Details of the piercing or cutting means
• CPC Class Codes: A61M 15/0045 using multiple prepacked dosages on a same carrier, e.g. blisters
• CPC Class Codes: A61M 15/0065 Inhalators with dosage or measuring devices A61M15/0028 takes precedence; dosage devices incorporated in aerosol cans B65D83/52
• CPC Class Codes: A61M 15/0086 Inhalation chambers
• CPC Class Codes: A61M 2202/064 Powder
• CPC Class Codes: A61M 2205/07 having air pumping means
• CPC Class Codes: A61M 2206/14 Static flow deviators in tubes disturbing laminar flow in tubes, e.g. archimedes screws

Abstract

A dry powder inhaler may include a powder storage, an inlet channel, a dispersion chamber, and an outlet channel. A geometry of the inhaler may be such that a flow profile is generated within the dispersion chamber that causes an actuator to oscillate, enabling the actuator when oscillating to deaggregate powdered medicament within the dispersion chamber to be aerosolized and entrained by the air and delivered to a patient through the outlet channel.

Claims

1. A dry powder inhaler, comprising:

a housing having a longitudinal axis, the housing comprising;

a powder receiving chamber within the housing that is adapted to receive an aerosolized powdered medicament from an inlet channel, wherein the inlet channel is in fluid communication with a powder storage location, and wherein the aerosolized powdered medicament flows generally axially along the longitudinal axis of the housing from the powder storage location through the inlet channel and into the powder receiving chamber;

a dispersion chamber within the housing downstream of the powder receiving chamber that is adapted to receive at least a portion of the aerosolized powdered medicament from the powder receiving chamber, the dispersion chamber comprising substantially cylindrical side walls that are coaxial with the longitudinal axis, the dispersion chamber holding a single actuator that oscillates in a generally axial direction along the longitudinal axis, wherein the aerosolized powdered medicament flows generally axially along the longitudinal axis of the housing through the powder receiving chamber and into the dispersion chamber; and

an outlet channel within the housing downstream of the dispersion chamber through which air and powdered medicament exit the inhaler to be delivered to a patient, wherein the aerosolized powdered medicament flows generally axially along the longitudinal axis of the housing through the dispersion chamber and into the outlet channel;

wherein a geometry of the inhaler is such that a flow profile is generated within the dispersion chamber that causes the single actuator to oscillate along the longitudinal axis, thus enabling the oscillating actuator to effectively disperse powdered medicament received in the dispersion chamber for delivery to the patient through the outlet channel; and

wherein the powder receiving chamber comprises continuous side walls to define a longitudinal flow path along the longitudinal axis from the powder receiving chamber to the dispersion chamber, and wherein the side walls of the dispersion chamber are continuous to define a longitudinal flow path along the longitudinal axis from the powder receiving chamber to the outlet channel, and wherein the outlet channel comprises continuous side walls to define a longitudinal flow path from the dispersion chamber to an outlet end of the outlet channel, and wherein the flow paths of the powder receiving chamber, the dispersion chamber and the outlet channel together define a single continuous flow path that extends from an inlet end of the inlet channel to the outlet end of the outlet channel through which the powdered medicament flows from the powder storage location to the outlet end of the outlet channel, wherein the continuous side walls that define the flow paths of the powder receiving chamber, the dispersion chamber, and the outlet channel prevent air from entering the single continuous flow path except for air that is introduced to the single continuous flow path via the inlet end of the inlet channel.

2. The dry powder inhaler of claim 1, wherein a cross-sectional area of a flow path through the inhaler undergoes a step increase at an entrance to the dispersion chamber.

3. The dry powder inhaler of claim 1, wherein a ratio of a diameter of the dispersion chamber to that of the inlet channel is within a range of about greater than 1.0 to about 3.0, and wherein a ratio of a length of the dispersion chamber to a diameter of the actuator is about 1.2 to 5.

4. The dry powder inhaler of claim 1, wherein the inlet channel comprises a tube.

5. The dry powder inhaler of claim 1, wherein the inlet channel comprises a tube with a cross-section that varies along a length of the tube.

6. The dry powder inhaler of claim 1, wherein the outlet channel comprises a tube with a cross-section that varies along a length of the tube.

7. The dry powder inhaler of claim 1, wherein the outlet channel is integral to a mouthpiece adapted to be placed within the mouth of the patient.

8. The dry powder inhaler of claim 1, wherein the outlet channel is integral to a nasal adapter adapted to conform to at least one nostril of the patient.

9. The dry powder inhaler of claim 1, further comprising one or more bypass channels that receive supplemental air from external the inhaler, and deliver the supplemental air to the patient without the supplemental air having passed through at least one of a powder storage chamber and the dispersion chamber.

10. The dry powder inhaler of claim 1, further comprising a coupling that connects the dispersion chamber to the powder receiving chamber.

11. The dry powder inhaler of claim 1, further comprising a coupling that connects the dispersion chamber to the powder receiving chamber, wherein the coupling is selected from one of:

a snap-fit coupling;

a pressure-fit coupling; and

a twist-to-fit coupling.

12. The dry powder inhaler of claim 1, further comprising a coupling that connects the dispersion chamber to the powder receiving chamber, wherein the coupling is integrally formed with dispersion chamber and removably coupled to the powder receiving chamber.

13. The dry powder inhaler of claim 1, wherein the dispersion chamber comprises an elongated geometry with a first end and a second end, the longitudinal axis extending between the first end and the second end, and wherein the single actuator oscillates between the first end and the second end generally along the longitudinal axis.

14. A dry powder inhaler system, comprising:

a receptacle containing an amount of powdered medicament; and

a housing having a longitudinal axis, the housing comprising;

an inlet channel that is adapted to receive air and powdered medicament from the receptacle;

a powder receiving chamber that is adapted to receive air and powdered medicament from the inlet channel;

a dispersion chamber that is adapted to receive air and powdered medicament from the powder receiving chamber, the dispersion chamber comprising substantially cylindrical side walls that are coaxial with the longitudinal axis, the dispersion chamber holding an actuator that is movable within the dispersion chamber along the longitudinal axis; and

an outlet channel through which air and powdered medicament exit the dispersion chamber to be delivered to a patient;

a flow bypass channel that extends through the housing to an outlet of the housing, wherein the flow bypass channel and the outlet channel are separated by a wall that blocks mixing of a fluid flowing through the flow bypass channel with the air and medicament flowing through the outlet channel in the housing;

wherein a geometry of the system is such that a flow profile is generated within the system that causes the actuator to oscillate along the longitudinal axis, thus enabling the oscillating actuator to effectively disperse powdered medicament received in the dispersion chamber for delivery to the patient through the outlet channel; and

wherein the powder receiving chamber comprises continuous side walls to define a longitudinal flow path along the longitudinal axis from the powder receiving chamber to the dispersion chamber, and wherein the side walls of the dispersion chamber are continuous to define a longitudinal flow path from the powder receiving chamber to the outlet channel, and wherein the outlet channel comprises continuous side walls to define a longitudinal flow path from the dispersion chamber to an outlet end of the outlet channel, and wherein the flow paths of the powder receiving chamber, the dispersion chamber and the outlet channel together define a single continuous flow path that extends from an inlet end of the inlet channel to the outlet end of the outlet channel through which the powdered medicament flows from a powder storage location to the outlet end of the outlet channel, wherein the continuous side walls that define the flow paths of the powder receiving chamber, the dispersion chamber and the outlet channel prevent air from entering the single continuous flow path except for air that is introduced to the single continuous flow path via the inlet end of the inlet channel.

15. The dry powder inhaler system of claim 14, further comprising a piercing member configured to perforate the receptacle to transfer air and powdered medicament to the inlet channel.

16. The dry powder inhaler system of claim 14, wherein the receptacle is selected from one of:

a capsule;

a blister; and

a powder reservoir.

17. The dry powder inhaler system of claim 14, wherein the actuator comprises a second powdered medicament adhered thereto, and wherein the geometry of the system is such that a flow profile is generated within the system that causes the actuator to oscillate along the longitudinal axis, thus enabling the oscillating actuator to effectively disperse the second powdered medicament received in the dispersion chamber for delivery to the patient through the outlet channel.

18. The dry powder inhaler system of claim 14, further comprising a first actuator in the powder receiving chamber, wherein the actuator in the dispersion chamber is a second actuator, wherein the geometry of the system is such that a flow profile is generated within the system that causes the first actuator to oscillate substantially along the longitudinal axis, thus enabling the oscillating first actuator to effectively disperse powdered medicament passing through the powder receiving chamber to be entrained by the air and delivered to the dispersion chamber.

19. A method for aerosolizing a powdered medicament, comprising:

providing an inhaler comprising a powder receiving chamber, and a dispersion chamber, the dispersion chamber comprising substantially cylindrical side walls, the dispersion chamber containing a single actuator that is movable within the dispersion chamber along a longitudinal axis, and an outlet channel, wherein the powder receiving chamber comprises continuous side walls to define a longitudinal flow path along the longitudinal axis from the powder receiving chamber to the dispersion chamber, and wherein the dispersion chamber comprises continuous side walls to define a longitudinal flow path from the powder receiving chamber to the outlet channel, and wherein the outlet channel comprises continuous side walls to define a longitudinal flow path from the dispersion chamber to an outlet end of the outlet channel, and wherein the flow paths of the powder receiving chamber, the dispersion chamber and the outlet channel together define a single continuous flow path from an inlet end of the powder receiving chamber to the outlet end of the outlet channel through which the powdered medicament flows from a powder storage location to the outlet end of the outlet channel, wherein the continuous side walls that define the flow paths of the powder receiving chamber, the dispersion chamber, and the outlet channel prevent air from entering the single continuous flow path except for air that is introduced to the single continuous flow path via the inlet end of the powder receiving chamber; and

inducing air flow and entrained medicament generally axially through the inhaler from the inlet end of the powder receiving chamber, through the dispersion chamber, and to an outlet end of the outlet channel along a longitudinal axis of the inhaler, and to cause the single actuator to oscillate within the dispersion chamber to effectively disperse powdered medicament passing through the powder receiving chamber and into the dispersion chamber for delivery to a patient through the outlet channel.

20. A method as in claim 19, wherein the powdered medicament is stored within a storage compartment, and wherein the powdered medicament is transferred from the storage compartment through an inlet channel and into the powder receiving chamber and dispersion chamber as flow is induced through the powder receiving chamber and dispersion chamber.

21. A method as in claim 19, further comprising inhaling from a mouthpiece to induce the flow through the powder receiving chamber and dispersion chamber.